Literature DB >> 27979847

Concomitant multiple myeloma, gastric adenocarcinoma and Evan's syndrome in a patient presenting with anaemia.

Maged Al-Ammari1, Soheir Adam2,3.   

Abstract

An association between multiple myeloma (MM) and solid tumours has been previously described.1 Furthermore, autoimmune disorders can precede plasma cell dyscrasias, and the pathogenesis of MM maybe linked to chronic immune stimulation. 2 We describe a case of concomitant MM and gastric adenocarcinoma preceded by Evan's syndrome. A previously healthy woman presented to the emergency room with symptomatic anaemia. Her initial workup was compatible with autoimmune haemolytic anaemia and monoclonal gammopathy of undetermined significance. On progression of the anaemia and development of thrombocytopenia, she was diagnosed with Evan's syndrome. Two months later, she presented with severe back pain and her MRI revealed L4-5 vertebral collapse. The clinical picture was compatible with MM. Occult blood was repeatedly positive in stools, and she underwent oesophagogastroduodenoscopy and was found to have gastric adenocarcinoma. The patient refused surgical resection of the adenocarcinoma and refused active treatment for MM. 2016 BMJ Publishing Group Ltd.

Entities:  

Mesh:

Year:  2016        PMID: 27979847      PMCID: PMC5174897          DOI: 10.1136/bcr-2016-217697

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  15 in total

Review 1.  Evans' syndrome associated with gastric plasmacytoma: case report and a review of the literature.

Authors:  S Yonekura; T Nagao; S Arimori; M Miyaji; K Ogoshi; Y Tsutsumi
Journal:  Jpn J Med       Date:  1990 Sep-Oct

Review 2.  Autoimmune hemolytic anemia as a paraneoplastic phenomenon in solid tumors: A critical analysis of 52 cases reported in the literature.

Authors:  Joe Puthenparambil; Klaus Lechner; Gabriela Kornek
Journal:  Wien Klin Wochenschr       Date:  2010-04       Impact factor: 1.704

3.  Autoimmune diseases, asthma and risk of haematological malignancies: a nationwide case-control study in Sweden.

Authors:  Karin C Söderberg; Fredrik Jonsson; Ola Winqvist; Lars Hagmar; Maria Feychting
Journal:  Eur J Cancer       Date:  2006-09-01       Impact factor: 9.162

4.  Multiple myeloma complicated by Evans syndrome.

Authors:  Y Yi; G S Zhang; F J Gong; J J Yang
Journal:  Intern Med J       Date:  2009-06       Impact factor: 2.048

5.  [A case of multiple myeloma associated with operated stomach cancer].

Authors:  A Yasuma; I Nakashima; M Muramatsu; T Aoki; H Ota
Journal:  Rinsho Ketsueki       Date:  1973-06

Review 6.  Secondary malignancies following cancer chemotherapy.

Authors:  P Boffetta; J M Kaldor
Journal:  Acta Oncol       Date:  1994       Impact factor: 4.089

7.  [A case of non-secretory myeloma (accompanied with gastric carcinoma) analyzed with plaque forming cell assay].

Authors:  S Matsushita; H Matsuzaki; F Kawano; H Mitsuya; K Yamaguchi; K Sakurai; K Takatsuki; M Takemiya
Journal:  Rinsho Ketsueki       Date:  1984-03

8.  Second malignancies and chemotherapeutic agents.

Authors:  R A Kyle
Journal:  Prog Clin Biol Res       Date:  1983

9.  Multiple myeloma in association with second malignancy.

Authors:  J Grudeva-Popova; I Nenova; M Spasova; M Yaneva; E Beleva; N Ananoshtev
Journal:  J BUON       Date:  2013 Apr-Jun       Impact factor: 2.533

Review 10.  Autoimmune manifestations in patients with multiple myeloma and monoclonal gammopathy of undetermined significance.

Authors:  Alexei Shimanovsky; Juliana Alvarez Argote; Shruti Murali; Constantin A Dasanu
Journal:  BBA Clin       Date:  2016-05-25
View more
  2 in total

1.  A Rare Case of Multiple Myeloma Presenting as Evan's Syndrome.

Authors:  Anthony Karapetians; Tushar Bajaj; Amanda Valdes; Arash Heidari
Journal:  J Investig Med High Impact Case Rep       Date:  2019 Jan-Dec

2.  A Case of Multiple Myeloma Presenting with Gastrointestinal Bleeding and Evans Syndrome.

Authors:  Muhammad S Khan; Rahil Kasmani; Ghazal Khan; Khalid Changal; Hemindermeet Singh
Journal:  Cureus       Date:  2019-10-22
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.